SCHEMBL6447100

SCHEMBL6447100

[CH2]CC(S)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.39
SHBG P04278 1/20 0.39
TP53 P04637 2/20 0.36
LMNA P02545 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GMNN O75496 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP2D6 P10635 2/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30
MLNR O43193 1/20 0.30
ABCB11 O95342 1/20 0.30
EGFR P00533 1/20 0.30
FYN P06241 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11834390 0.76 EPHX1 (0.40) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL13619070 0.74 SHBG (0.56) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL904038 0.74 EPHX1 (0.56) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL4654285 0.72 EPHX1 (0.55) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL9213980 0.72 EPHX1 (0.42) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL23082587 0.70
SCHEMBL11698385 0.70
SCHEMBL3263270 0.70 EPHX1 (0.40) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL21175606 0.70 SHBG (0.46) EPHX1SHBGTP53LMNAKDM4E
SCHEMBL7285053 0.70 EPHX1 (0.36) EPHX1SHBGTP53LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103172870-B Polyhedral oligomeric silsesquioxane (POSS) modified double-bond containing elastomer and preparation method thereof UNIV BEIJING CHEMICAL 2015-04-29 CN claimed
CN-103172870-A Polyhedral oligomeric silsesquioxane (POSS) modified double-bond containing elastomer and preparation method thereof UNIV BEIJING CHEMICAL 2013-06-26 CN claimed
CN-105367599-B A kind of 3- cyclohexyl thio -1- propyl-triethoxysilane and its preparation method and application 山东阳谷华泰化工股份有限公司 2018-11-23 CN disclosed
CN-103172870-B Polyhedral oligomeric silsesquioxane (POSS) modified double-bond containing elastomer and preparation method thereof UNIV BEIJING CHEMICAL 2015-04-29 CN disclosed
CN-103172870-A Polyhedral oligomeric silsesquioxane (POSS) modified double-bond containing elastomer and preparation method thereof UNIV BEIJING CHEMICAL 2013-06-26 CN disclosed
US-8362264-B2 Tryptophan antagonist; anticancer agents DENDREON CORPORATION (US) 2013-01-29 US disclosed
CN-1239642-C Anthraquinone compound and aqueous ink for inkjet recording using the same MITSUI CHEMICALS INC (JP) 2006-02-01 CN disclosed
CN-1218001-C Yellow toner compound and aqueous ink for ink-jet recording apparatus using the same MITSUI CHEMICALS INC (JP) 2005-09-07 CN disclosed
US-20050054651-A1 Compositions and methods for the treatment of disease associated with Trp-p8 expression DENDREON CORPORATION (US) 2005-03-10 US disclosed
CN-1366543-A Anthraquinone compound and aqueous ink for inkjet recording using the same MITSUI CHEMICALS INC (JP) 2002-08-28 CN disclosed
CN-1322227-A Yellow toner compound and aqueous ink for ink-jet recording apparatus using the same MITSUI CHEMICALS INC (JP) 2001-11-14 CN disclosed
CN-1110875-A Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent OTSUKA PHARMA CO LTD (JP) 1995-10-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054651-A1 Compositions and methods for the treatment of disease associated with Trp-p8 expression TRPC4, TRPC3, TRPC1 EPHX1 2270/4885SHBG 3730/4885TP53 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.